Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 4th edition, 372 pages + the daily Top 10

Lung Cancer

Free Subscription Articles published in Eur J Cardiothorac Surg Retrieve available abstracts of 114 articles: HTML format

Single Articles

September 2020
1. KAMIGAICHI A, Tsutani Y, Mimae T, Miyata Y, et al
   Prognosis of segmentectomy and lobectomy for radiologically aggressive small-sized lung cancer.
   Eur J Cardiothorac Surg. 2020 Sep 7. pii: 5902140. doi: 10.1093.
   PubMed     Abstract available
   
   
   
2. GONFIOTTI A, Gatteschi L, Salvicchi A, Bongiolatti S, et al
   Clinical courses and outcomes of five patients with primary lung cancer surgically treated while affected by Severe acute respiratory syndrome coronavirus 2.
   Eur J Cardiothorac Surg. 2020;58:598-604.
   PubMed     Abstract available
   
   
   August 2020
3. CORSINI EM, Weissferdt A, Pataer A, Zhou N, et al
   Pathological nodal disease defines survival outcomes in patients with lung cancer with tumour major pathological response following neoadjuvant chemotherapy.
   Eur J Cardiothorac Surg. 2020 Aug 30. pii: 5899328. doi: 10.1093.
   PubMed     Abstract available
   
   
   
4. FIORELLI S, Massullo D, Ibrahim M, Piccioni F, et al
   Perspectives in surgical and anaesthetic management of lung cancer in the era of coronavirus disease 2019 (COVID-19).
   Eur J Cardiothorac Surg. 2020 Aug 26. pii: 5897205. doi: 10.1093.
   PubMed     Abstract available
   
   
   
5. CHIAPPETTA M, Lococo F, Leuzzi G, Sperduti I, et al
   External validation of the N descriptor in the proposed tumour-node-metastasis subclassification for lung cancer: the crucial role of histological type, number of resected nodes and adjuvant therapy.
   Eur J Cardiothorac Surg. 2020 Aug 8. pii: 5885289. doi: 10.1093.
   PubMed     Abstract available
   
   
   July 2020
6. NAKAGAWA K, Yoshida Y, Yotsukura M, Watanabe SI, et al
   Pattern of recurrence of pN2 non-small-cell lung cancer: should postoperative radiotherapy be reconsidered?
   Eur J Cardiothorac Surg. 2020 Jul 30. pii: 5878241. doi: 10.1093.
   PubMed     Abstract available
   
   
   
7. TEN BERGE MG, Beck N, Steup WH, Verhagen AFTM, et al
   Textbook outcome as a composite outcome measure in non-small-cell lung cancer surgery.
   Eur J Cardiothorac Surg. 2020 Jul 30. pii: 5878242. doi: 10.1093.
   PubMed     Abstract available
   
   
   May 2020
8. WU D, Liang H, Liang W, Liu H, et al
   Spontaneous ventilation video-assisted thoracoscopic surgery for patients with non-small-cell lung cancer with excess body weight.
   Eur J Cardiothorac Surg. 2020 May 23. pii: 5843501. doi: 10.1093.
   PubMed     Abstract available
   
   
   April 2020
9. VAN DORP M, Beck N, Steup WH, Schreurs WH, et al
   Surgical treatment of pulmonary metastases in the Netherlands: data from the Dutch Lung Cancer Audit for Surgery.
   Eur J Cardiothorac Surg. 2020 Apr 13. pii: 5819620. doi: 10.1093.
   PubMed     Abstract available
   
   
   
10. BOCCHIALINI G, Lagrasta C, Madeddu D, Mazzaschi G, et al
    Spatial architecture of tumour-infiltrating lymphocytes as a prognostic parameter in resected non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2020 Apr 8. pii: 5817917. doi: 10.1093.
    PubMed     Abstract available
    
    
    
11. HINO H, Saito T, Matsui H, Taniguchi Y, et al
    Utility of Geriatric Nutritional Risk Index in patients with lung cancer undergoing surgery.
    Eur J Cardiothorac Surg. 2020 Apr 1. pii: 5814344. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2020
12. DENG HY, Wang T, Tang X
    Should the left lower paratracheal lymph node always be dissected in patients with left-sided lung cancer?
    Eur J Cardiothorac Surg. 2020 Mar 26. pii: 5811876. doi: 10.1093.
    PubMed    
    
    
    
13. ZHANG X, Jiang Y, Zhang L
    L4 lymph node dissection in left-side operable non-small-cell lung cancer: one size fits all?
    Eur J Cardiothorac Surg. 2020 Mar 25. pii: 5811875. doi: 10.1093.
    PubMed    
    
    
    
14. CHOI S, Park J
    Surgical outcomes and prognosis of non-small-cell lung cancer in patients with chronic lung diseases: a retrospective analysis.
    Eur J Cardiothorac Surg. 2020 Mar 12. pii: 5804139. doi: 10.1093.
    PubMed     Abstract available
    
    
    
15. YUN JK, Bok JS, Lee GD, Kim HR, et al
    Long-term outcomes of upfront surgery in patients with resectable pathological N2 non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2020 Mar 10. pii: 5802580. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2020
16. LOCOCO F, Chiappetta M, Cesario A, Margaritora S, et al
    Non-small-cell lung cancer with pathological complete response after induction therapy followed by surgical resection: which is the pattern of failure and which are the future perspectives?
    Eur J Cardiothorac Surg. 2020 Feb 27. pii: 5762453. doi: 10.1093.
    PubMed    
    
    
    
17. DENG HY, Tang X
    Is less more for early-stage non-small-cell lung cancer? Current evidence for performing segmentectomy.
    Eur J Cardiothorac Surg. 2020 Feb 24. pii: 5753895. doi: 10.1093.
    PubMed    
    
    
    
18. CASIRAGHI M, Bertolaccini L, Sedda G, Petrella F, et al
    Lung cancer surgery in oligometastatic patients: outcome and survival.
    Eur J Cardiothorac Surg. 2020 Feb 24. pii: 5753896. doi: 10.1093.
    PubMed     Abstract available
    
    
    
19. JONES GD, Caso R, No JS, Tan KS, et al
    Prognostic factors following complete resection of non-superior sulcus lung cancer invading the chest wall.
    Eur J Cardiothorac Surg. 2020 Feb 10. pii: 5732798. doi: 10.1093.
    PubMed     Abstract available
    
    
    
20. REA F, Ieva F, Pastorino U, Apolone G, et al
    Number of lung resections performed and long-term mortality rates of patients after lung cancer surgery: evidence from an Italian investigation.
    Eur J Cardiothorac Surg. 2020 Feb 8. pii: 5731323. doi: 10.1093.
    PubMed     Abstract available
    
    
    
21. YANG MZ, Hou X, Li JB, Cai JS, et al
    Impact of L4 lymph node dissection on long-term survival in left-side operable non-small-cell lung cancer: a propensity score matching study.
    Eur J Cardiothorac Surg. 2020 Feb 4. pii: 5722182. doi: 10.1093.
    PubMed     Abstract available
    
    
    
22. OPITZ I, Patella M, Payrard L, Perentes JY, et al
    Prognostic factors of oligometastatic non-small-cell lung cancer following radical therapy: a multicentre analysis.
    Eur J Cardiothorac Surg. 2020 Feb 3. pii: 5721431. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2020
23. INCI I, Benker M, Citak N, Schneiter D, et al
    Complex sleeve lobectomy has the same surgical outcome when compared with conventional lobectomy in patients with lung cancer.
    Eur J Cardiothorac Surg. 2020 Jan 9. pii: 5699252. doi: 10.1093.
    PubMed     Abstract available
    
    
    
24. WINCKELMANS T, Decaluwe H, De Leyn P, Van Raemdonck D, et al
    Segmentectomy or lobectomy for early-stage non-small-cell lung cancer: a systematic review and meta-analysis.
    Eur J Cardiothorac Surg. 2020 Jan 3. pii: 5695530. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2019
25. BOLUKBAS S, Baldes N, Eberlein M
    Surveillance and screening in lung cancer survivors.
    Eur J Cardiothorac Surg. 2019 Dec 6. pii: 5662417. doi: 10.1093.
    PubMed    
    
    
    
26. LANUTI M
    T4 disease: exploring changes in the 8th edition of the TNM classification of lung cancer and pushing the limits.
    Eur J Cardiothorac Surg. 2019 Dec 6. pii: 5662414. doi: 10.1093.
    PubMed    
    
    
    November 2019
27. HENNON MW, DeGraaff LH, Groman A, Demmy TL, et al
    The association of nodal upstaging with surgical approach and its impact on long-term survival after resection of non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2019 Nov 25. pii: 5640487. doi: 10.1093.
    PubMed     Abstract available
    
    
    
28. SETOJIMA Y, Shimada Y, Tanaka T, Shigefuku S, et al
    Prognostic impact of solid-part tumour volume doubling time in patients with radiological part-solid or solid lung cancer.
    Eur J Cardiothorac Surg. 2019 Nov 20. pii: 5634181. doi: 10.1093.
    PubMed     Abstract available
    
    
    
29. TAN HX, Drake BC, Chaudhuri N, Kefaloyannis M, et al
    A risk model to predict 2-year survival after VATS lobectomy for non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2019 Nov 13. pii: 5625090. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2019
30. MITCHELL J, Benamore R, Gleeson F, Belcher E, et al
    Computed tomography follow-up identifies radically treatable new primaries after resection for lung cancer.
    Eur J Cardiothorac Surg. 2019 Oct 25. pii: 5607278. doi: 10.1093.
    PubMed     Abstract available
    
    
    
31. YAMANASHI K, Menju T, Hamaji M, Tanaka S, et al
    Prognostic factors related to postoperative survival in the newly classified clinical T4 lung cancer.
    Eur J Cardiothorac Surg. 2019 Oct 21. pii: 5601458. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2019
32. LI P, Che G
    Should there be any restriction for stage IA non-small-cell lung cancer patients to receive segmentectomy?
    Eur J Cardiothorac Surg. 2019 Aug 25. pii: 5554421. doi: 10.1093.
    PubMed    
    
    
    
33. OLLAND A, Falcoz PE
    Complex segmentectomy in the treatment of stage IA non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2019 Aug 1. pii: 5542615. doi: 10.1093.
    PubMed    
    
    
    July 2019
34. DENG HY, Tang X, Zhou Q
    Sublobar resection: an alternative to lobectomy in treating stage I non-small-cell lung cancer?
    Eur J Cardiothorac Surg. 2019 Jul 25. pii: 5538725. doi: 10.1093.
    PubMed    
    
    
    June 2019
35. VALO JK, Kyto V, Sipila J, Rautava P, et al
    Thoracoscopic surgery for lung cancer is associated with improved survival and shortened admission length: a nationwide propensity-matched study.
    Eur J Cardiothorac Surg. 2019 Jun 26. pii: 5523684. doi: 10.1093.
    PubMed     Abstract available
    
    
    
36. HANDA Y, Tsutani Y, Mimae T, Miyata Y, et al
    Complex segmentectomy in the treatment of stage IA non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2019 Jun 23. pii: 5522159. doi: 10.1093.
    PubMed     Abstract available
    
    
    
37. YUN JK, Lee GD, Choi S, Kim HR, et al
    Comparison between lymph node station- and zone-based classification for the future revision of node descriptors proposed by the International Association for the Study of Lung Cancer in surgically resected patients with non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2019 Jun 5. pii: 5511574. doi: 10.1093.
    PubMed     Abstract available
    
    
    
38. STILES BM, Mao J, Harrison S, Lee B, et al
    Sublobar resection for node-negative lung cancer 2-5 cm in size.
    Eur J Cardiothorac Surg. 2019 Jun 5. pii: 5511701. doi: 10.1093.
    PubMed     Abstract available
    
    
    
39. MARIJIC P, Walter J, Schneider C, Schwarzkopf L, et al
    Cost and survival of video-assisted thoracoscopic lobectomy versus open lobectomy in lung cancer patients: a propensity score-matched study.
    Eur J Cardiothorac Surg. 2019 Jun 3. pii: 5510143. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2019
40. BENDIXEN M, Kronborg C, Jorgensen OD, Andersen C, et al
    Cost-utility analysis of minimally invasive surgery for lung cancer: a randomized controlled trial.
    Eur J Cardiothorac Surg. 2019 Mar 5. pii: 5369803. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2019
41. MELEK H, Cetinkaya G, Ozer E, Yenturk E, et al
    Pathological complete response after neoadjuvant/induction treatment: where is its place in the lung cancer staging system?dagger.
    Eur J Cardiothorac Surg. 2019 Feb 26. pii: 5365486. doi: 10.1093.
    PubMed     Abstract available
    
    
    
42. LI H, Sun Z, Yang F, Sui X, et al
    Primary tumour resection in non-small-cell lung cancer patients with ipsilateral pleural dissemination (M1a): a population-based study.
    Eur J Cardiothorac Surg. 2019 Feb 4. pii: 5306618. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2018
43. TANAKA S, Sugimoto S, Soh J, Oto T, et al
    Long-term outcomes of pneumonectomy, back-table lung preservation, double-sleeve resection and reimplantation for advanced central lung cancer: the Oto procedure.
    Eur J Cardiothorac Surg. 2018 Dec 24. pii: 5259358. doi: 10.1093.
    PubMed     Abstract available
    
    
    
44. DENG HY, Zha P, Zhou Q
    Sarcopenia: an unneglectable nutritional status for patients with surgically treated non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2018 Dec 18. pii: 5251904. doi: 10.1093.
    PubMed    
    
    
    November 2018
45. LI Q, Zhang P, Wang Y, Liu D, et al
    T4 extension alone is more predictive of better survival than a tumour size >7 cm for resected T4N0-1M0 non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2018 Nov 30. pii: 5224799. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2018
46. NGUYEN D, Gharagozloo F, Tempesta B, Meyer M, et al
    Long-term results of robotic anatomical segmentectomy for early-stage non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2018 Oct 15. pii: 5133000. doi: 10.1093.
    PubMed     Abstract available
    
    
    
47. SUN C, Anraku M, Karasaki T, Kuwano H, et al
    Low truncal muscle area on chest computed tomography: a poor prognostic factor for the cure of early-stage non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2018 Oct 4. pii: 5115406. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2018
48. CHIAPPETTA M, Leuzzi G, Sperduti I, Bria E, et al
    Lymph-node ratio predicts survival among the different stages of non-small-cell lung cancer: a multicentre analysis.
    Eur J Cardiothorac Surg. 2018 Sep 6. pii: 5092028. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2018
49. MOKHLES S, Macbeth F, Treasure T, Younes RN, et al
    Corrigendum to 'Systematic lymphadenectomy versus sampling of ipsilateral mediastinal lymph-nodes during lobectomy for non-small cell lung cancer: a systematic review of randomized trials and a meta-analysis' [Eur J Cardiothorac Surg 2017;51:1149-1156
    Eur J Cardiothorac Surg. 2018 Aug 16. pii: 5075054. doi: 10.1093.
    PubMed    
    
    
    
50. SUCIU BA, Halmaciu I, Vunvulea V, Brinzaniuc K, et al
    Is there any correlation between pretreatment haemoglobin levels and prognosis of patients with non-small-cell lung cancer?
    Eur J Cardiothorac Surg. 2018 Aug 8. pii: 5068216. doi: 10.1093.
    PubMed    
    
    
    July 2018
51. VARELA G, Novoa NM
    Re: Oncological results of full thoracoscopic major pulmonary resections for clinical Stage I non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2018 Jul 27. pii: 5060691. doi: 10.1093.
    PubMed    
    
    
    
52. LUTZ JA, Seguin-Givelet A, Grigoroiu M, Brian E, et al
    Oncological results of full thoracoscopic major pulmonary resections for clinical Stage I non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2018 Jul 24. pii: 5058116. doi: 10.1093.
    PubMed     Abstract available
    
    
    
53. SANO Y, Shigematsu H, Okazaki M, Sakao N, et al
    Hoarseness after radical surgery with systematic lymph node dissection for primary lung cancer.
    Eur J Cardiothorac Surg. 2018 Jul 13. pii: 5053975. doi: 10.1093.
    PubMed     Abstract available
    
    
    
54. AIGNER C
    To be or not to be central-does this really matter?
    Eur J Cardiothorac Surg. 2018;54:141.
    PubMed    
    
    
    
55. RESCIGNO G, Hogan J, Strong P
    The ideal use of dogs in medicine.
    Eur J Cardiothorac Surg. 2018;54:197.
    PubMed    
    
    
    May 2018
56. FALCOZ PE
    Re: Video-assisted thoracoscopic surgery yields better outcomes than thoracotomy for anatomical lung resection in Brazil: a propensity score-matching analysis using the Brazilian Society of Thoracic Surgery database.
    Eur J Cardiothorac Surg. 2018;53:999-1000.
    PubMed    
    
    
    April 2018
57. VERONESI G, Park B, Cerfolio R, Dylewski M, et al
    Robotic resection of Stage III lung cancer: an international retrospective study.
    Eur J Cardiothorac Surg. 2018 Apr 30. pii: 4990523. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2018
58. PAN X, Gu C, Yang J, Shi J, et al
    Robotic double-sleeve resection of lung cancer: technical aspects.
    Eur J Cardiothorac Surg. 2018 Mar 20. pii: 4944680. doi: 10.1093.
    PubMed     Abstract available
    
    
    
59. DZIEDZIC R, Marjanski T, Binczyk F, Polanska J, et al
    Favourable outcomes in patients with early-stage non-small-cell lung cancer operated on by video-assisted thoracoscopic surgery: a propensity score-matched analysis.
    Eur J Cardiothorac Surg. 2018 Mar 14. pii: 4934946. doi: 10.1093.
    PubMed     Abstract available
    
    
    
60. BATIREL HF
    Solid to ground-glass opacity ratio in lung adenocarcinomas: is it a new criterion for limited pulmonary resection?
    Eur J Cardiothorac Surg. 2018 Mar 8. pii: 4924815. doi: 10.1093.
    PubMed    
    
    
    
61. VON MEYENFELDT EM, Marres GMH, van Thiel E, Damhuis RAM, et al
    Variation in length of hospital stay after lung cancer surgery in the Netherlands.
    Eur J Cardiothorac Surg. 2018 Mar 5. pii: 4921284. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2018
62. CHO S, Yum S, Kim K, Jheon S, et al
    Prognostic factors for post-recurrence survival in patients with completely resected Stage III (N2) non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2018 Feb 27. pii: 4912385. doi: 10.1093.
    PubMed     Abstract available
    
    
    
63. DECALUWE H, Moons J, Fieuws S, De Wever W, et al
    Is central lung tumour location really predictive for occult mediastinal nodal disease in (suspected) non-small-cell lung cancer staged cN0 on 18F-fluorodeoxyglucose positron emission tomography-computed tomography?
    Eur J Cardiothorac Surg. 2018 Feb 13. pii: 4855994. doi: 10.1093.
    PubMed     Abstract available
    
    
    
64. WANG G, Ma W, Li Y, Jiang Y, et al
    Prognostic value of Twist, Snail and E-cadherin expression in pathological N0 non-small-cell lung cancer: a retrospective cohort study.
    Eur J Cardiothorac Surg. 2018 Feb 5. pii: 4838788. doi: 10.1093.
    PubMed     Abstract available
    
    
    
65. HONG TH, Cho JH, Shin S, Kim HK, et al
    Extended sleeve lobectomy for centrally located non-small-cell lung cancer: a 20-year single-centre experience.
    Eur J Cardiothorac Surg. 2018 Feb 2. pii: 4835395. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2018
66. ARMANI G, Madeddu D, Mazzaschi G, Bocchialini G, et al
    Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2018 Jan 15. pii: 4810371. doi: 10.1093.
    PubMed     Abstract available
    
    
    
67. GUNN J, Valo J, Sipila J, Rautava P, et al
    Trends and results of lung cancer surgery in Finland between 2004 and 2014.
    Eur J Cardiothorac Surg. 2018 Jan 8. pii: 4793386. doi: 10.1093.
    PubMed     Abstract available
    
    
    
68. XIAO F, Yu Q, Zhang Z, Liu D, et al
    Novel perspective to evaluate the safety of segmentectomy: clinical significance of lobar and segmental lymph node metastasis in cT1N0M0 lung adenocarcinoma.
    Eur J Cardiothorac Surg. 2018;53:228-234.
    PubMed     Abstract available
    
    
    December 2017
69. XIE D, Allen MS, Marks R, Jiang G, et al
    Nomogram prediction of overall survival for patients with non-small-cell lung cancer incorporating pretreatment peripheral blood markers.
    Eur J Cardiothorac Surg. 2017 Dec 27. pii: 4780277. doi: 10.1093.
    PubMed     Abstract available
    
    
    
70. TAMBURINI N, Maniscalco P, Mazzara S, Maietti E, et al
    Multidisciplinary management improves survival at 1 year after surgical treatment for non-small-cell lung cancer: a propensity score-matched study.
    Eur J Cardiothorac Surg. 2017 Dec 25. pii: 4774618. doi: 10.1093.
    PubMed     Abstract available
    
    
    
71. WEDER W, Moghanaki D, Stiles B, Siva S, et al
    The great debate flashes: Surgery versus stereotactic body radiotherapy as the primary treatment of early-stage lung cancer.
    Eur J Cardiothorac Surg. 2017 Dec 21. pii: 4772266. doi: 10.1093.
    PubMed     Abstract available
    
    
    
72. HINO H, Karasaki T, Yoshida Y, Fukami T, et al
    Risk factors for postoperative complications and long-term survival in lung cancer patients older than 80 years.
    Eur J Cardiothorac Surg. 2017 Dec 18. pii: 4759172. doi: 10.1093.
    PubMed     Abstract available
    
    
    
73. YENDAMURI S, Groman A, Miller A, Demmy T, et al
    Risk and benefit of neoadjuvant therapy among patients undergoing resection for non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2017 Dec 13. pii: 4740938. doi: 10.1093.
    PubMed     Abstract available
    
    
    
74. SAJI H, Ueno T, Nakamura H, Okumura N, et al
    A proposal for a comprehensive risk scoring system for predicting postoperative complications in octogenarian patients with medically operable lung cancer: JACS1303.
    Eur J Cardiothorac Surg. 2017 Dec 11. pii: 4731648. doi: 10.1093.
    PubMed     Abstract available
    
    
    
75. SAGAWA M, Oizumi H, Suzuki H, Uramoto H, et al
    A prospective 5-year follow-up study after limited resection for lung cancer with ground-glass opacity.
    Eur J Cardiothorac Surg. 2017 Dec 9. pii: 4718127. doi: 10.1093.
    PubMed     Abstract available
    
    
    
76. TAKIZAWA H, Kondo K, Kawakita N, Tsuboi M, et al
    Autofluorescence for the diagnosis of visceral pleural invasion in non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2017 Dec 8. pii: 4710341. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2017
77. STILES BM, Rahouma M, Hussein MK, Nasar A, et al
    Never smokers with resected lung cancer: different demographics, similar survival.
    Eur J Cardiothorac Surg. 2017 Nov 22. pii: 4652925. doi: 10.1093.
    PubMed     Abstract available
    
    
    
78. SAWABATA N
    Pulmonary wedge resection for Stage I non-small-cell lung cancer: possible alternative strategy to lobectomy.
    Eur J Cardiothorac Surg. 2017 Nov 3. doi: 10.1093.
    PubMed    
    
    
    October 2017
79. DE WOLF J, Bellier J, Lepimpec-Barthes F, Tronc F, et al
    Exhaustive preoperative staging increases survival in resected adrenal oligometastatic non-small-cell lung cancer: a multicentre study.
    Eur J Cardiothorac Surg. 2017;52:698-703.
    PubMed     Abstract available
    
    
    September 2017
80. GU C, Pan X, Chen Y, Yang J, et al
    Short-term and mid-term survival in bronchial sleeve resection by robotic system versus thoracotomy for centrally located lung cancer.
    Eur J Cardiothorac Surg. 2017 Sep 27. doi: 10.1093.
    PubMed     Abstract available
    
    
    
81. DECALUWE H, Petersen RH, Brunelli A, Pompili C, et al
    Multicentric evaluation of the impact of central tumour location when comparing rates of N1 upstaging in patients undergoing video-assisted and open surgery for clinical Stage I non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2017 Sep 27. doi: 10.1093.
    PubMed     Abstract available
    
    
    
82. TSUTANI Y, Tsubokawa N, Ito M, Misumi K, et al
    Postoperative complications and prognosis after lobar resection versus sublobar resection in elderly patients with clinical Stage I non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2017 Sep 6. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2017
83. YANG S, Guo W, Chen X, Wu H, et al
    Early outcomes of robotic versus uniportal video-assisted thoracic surgery for lung cancer: a propensity score-matched study.
    Eur J Cardiothorac Surg. 2017 Aug 30. doi: 10.1093.
    PubMed     Abstract available
    
    
    
84. ABAH U, Casali G, Batchelor TJP, Internullo E, et al
    Pathological lymph node involvement is not a predictor of adverse outcomes in patients undergoing thoracoscopic lobectomy for lung cancer.
    Eur J Cardiothorac Surg. 2017 Aug 29. doi: 10.1093.
    PubMed     Abstract available
    
    
    
85. UDA K, Matsui H, Fushimi K, Yasunaga H, et al
    Preoperative short-term plus postoperative physical therapy versus postoperative physical therapy alone for patients undergoing lung cancer surgery: retrospective analysis of a nationwide inpatient database.
    Eur J Cardiothorac Surg. 2017 Aug 18. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2017
86. MAO Y, Chi C, Yang F, Zhou J, et al
    The identification of sub-centimetre nodules by near-infrared fluorescence thoracoscopic systems in pulmonary resection surgeries.
    Eur J Cardiothorac Surg. 2017 Jul 27. doi: 10.1093.
    PubMed     Abstract available
    
    
    
87. ZEHNDER A, Kocher GJ, Seitz M, Schmid RA, et al
    IgG4-related disease of the lung: a rare differential diagnosis to lung cancer after positive positron emission tomography and biopsy.
    Eur J Cardiothorac Surg. 2017 Jul 25. doi: 10.1093.
    PubMed     Abstract available
    
    
    
88. BUGGE AS, Lund MB, Valberg M, Brustugun OT, et al
    Cause-specific death after surgical resection for early-stage non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2017 Jul 25. doi: 10.1093.
    PubMed     Abstract available
    
    
    
89. GUIRAO MONTES A, Molins Lopez-Rodo L, Ramon Rodriguez I, Sunyer Dequigiovanni G, et al
    Lung cancer diagnosis by trained dogs.
    Eur J Cardiothorac Surg. 2017 Jul 24. doi: 10.1093.
    PubMed     Abstract available
    
    
    
90. ENDO S, Ikeda N, Kondo T, Nakajima J, et al
    Model of lung cancer surgery risk derived from a Japanese nationwide web-based database of 78 594 patients during 2014-2015.
    Eur J Cardiothorac Surg. 2017 Jul 21. doi: 10.1093.
    PubMed     Abstract available
    
    
    
91. PERIKLEOUS P, Bilancia R, Oey I, Waller DA, et al
    Hybrid bilobectomy for treatment of an early-stage lung cancer in a patient with severe emphysema using the benefits of lung volume reduction.
    Eur J Cardiothorac Surg. 2017 Jul 21. doi: 10.1093.
    PubMed     Abstract available
    
    
    
92. YANG CC, Fong Y, Lin LC, Que J, et al
    The age-adjusted Charlson comorbidity index is a better predictor of survival in operated lung cancer patients than the Charlson and Elixhauser comorbidity indices.
    Eur J Cardiothorac Surg. 2017 Jul 4. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2017
93. CAGINI L, Balloni S, Ludovini V, Andolfi M, et al
    Variations in gene expression of lung macromolecules after induction chemotherapy for lung cancer.
    Eur J Cardiothorac Surg. 2017 Jun 19. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2017
94. SEKIHARA K, Hishida T, Yoshida J, Oki T, et al
    Long-term survival outcome after postoperative recurrence of non-small-cell lung cancer: who is 'cured' from postoperative recurrence?
    Eur J Cardiothorac Surg. 2017 May 8. doi: 10.1093.
    PubMed     Abstract available
    
    
    
95. NAKAJIMA J, Iida T, Okumura S, Horio H, et al
    Recent improvement of survival prognosis after pulmonary metastasectomy and advanced chemotherapy for patients with colorectal cancer.
    Eur J Cardiothorac Surg. 2017;51:869-873.
    PubMed     Abstract available
    
    
    
96. NOVOA NM, Esteban P, Rodriguez M, Gomez MT, et al
    Functional evaluation before lung resection: searching for a low technology test in a safer environment for the patient: a pilot study.
    Eur J Cardiothorac Surg. 2017;51:856-860.
    PubMed     Abstract available
    
    
    
97. CATTONI M, Vallieres E, Brown LM, Sarkeshik AA, et al
    Is there a role for traditional nuclear medicine imaging in the management of pulmonary carcinoid tumours?
    Eur J Cardiothorac Surg. 2017;51:874-879.
    PubMed     Abstract available
    
    
    
98. SATO M, Kuwata T, Yamanashi K, Kitamura A, et al
    Safety and reproducibility of virtual-assisted lung mapping: a multicentre study in Japan.
    Eur J Cardiothorac Surg. 2017;51:861-868.
    PubMed     Abstract available
    
    
    April 2017
99. FILOSSO PL, Guerrera F, Evangelista A, Galassi C, et al
    Adjuvant chemotherapy for large-cell neuroendocrine lung carcinoma: results from the European Society for Thoracic Surgeons Lung Neuroendocrine Tumours Retrospective Database.
    Eur J Cardiothorac Surg. 2017 Apr 28. doi: 10.1093.
    PubMed     Abstract available
    
    
    
100. BENDIXEN M, Licht PB
     Video-assisted thoracoscopic surgery versus open lobectomy for lung cancer: time for a randomized trialdagger.
     Eur J Cardiothorac Surg. 2017 Apr 27. doi: 10.1093.
     PubMed    
     
     
     
101. KARENOVICS W, Licker M, Ellenberger C, Christodoulou M, et al
     Short-term preoperative exercise therapy does not improve long-term outcome after lung cancer surgery: a randomized controlled studydagger.
     Eur J Cardiothorac Surg. 2017 Apr 17. doi: 10.1093.
     PubMed     Abstract available
     
     
     
102. WELTER S, Arfanis E, Christoph D, Hager T, et al
     Growth patterns of pulmonary metastases: should we adjust resection techniques to primary histology and size?dagger.
     Eur J Cardiothorac Surg. 2017 Apr 11. doi: 10.1093.
     PubMed     Abstract available
     
     
     
103. DZIEDZIC R, Zurek W, Marjanski T, Rudzinski P, et al
     Stage I non-small-cell lung cancer: long-term results of lobectomy versus sublobar resection from the Polish National Lung Cancer Registrydagger.
     Eur J Cardiothorac Surg. 2017 Apr 11. doi: 10.1093.
     PubMed     Abstract available
     
     
     
104. ANDERSON KL JR, Mulvihill MS, Yerokun BA, Speicher PJ, et al
     Induction chemotherapy for T3N0M0 non-small-cell lung cancer increases the rate of complete resection but does not confer improved survival.
     Eur J Cardiothorac Surg. 2017 Apr 11. doi: 10.1093.
     PubMed     Abstract available
     
     
     March 2017
105. SCHIRREN J, Schirren M, Lampl L, Sponholz S, et al
     Surgery for pulmonary metastases: quo vadis?
     Eur J Cardiothorac Surg. 2017;51:408-410.
     PubMed    
     
     
     December 2016
106. GUERRERA F, Renaud S, Tabbo F, Voegeli' AC, et al
     Epidermal growth factor receptor mutations are linked to skip N2 lymph node metastasis in resected non-small-cell lung cancer adenocarcinomasdagger.
     Eur J Cardiothorac Surg. 2016 Dec 15. doi: 10.1093.
     PubMed     Abstract available
     
     
     July 2016
107. HOFFERBERTH SC, Grinstaff MW, Colson YL
     Nanotechnology applications in thoracic surgery.
     Eur J Cardiothorac Surg. 2016;50:6-16.
     PubMed     Abstract available
     
     
     
108. DECALUWE H, Stanzi A, Dooms C, Fieuws S, et al
     Central tumour location should be considered when comparing N1 upstaging between thoracoscopic and open surgery for clinical stage I non-small-cell lung cancer.
     Eur J Cardiothorac Surg. 2016;50:110-7.
     PubMed     Abstract available
     
     
     
109. STAMENOVIC D, Bostanci K, Messerschmidt A, Jahn T, et al
     Fissureless fissure-last video-assisted thoracoscopic lobectomy for all lung lobes: a better alternative to decrease the incidence of prolonged air leak?
     Eur J Cardiothorac Surg. 2016;50:118-23.
     PubMed     Abstract available
     
     
     
110. CHIAPPETTA M, Nachira D, Margaritora S, Granone P, et al
     Are digital devices routinely useful in thoracic surgery or are they helpful only in selected cases?
     Eur J Cardiothorac Surg. 2016;50:192.
     PubMed    
     
     
     June 2016
111. KIRCHEVA DY, Husain AN, Watson S, Kindler HL, et al
     Specimen weight and volume: important predictors of survival in malignant pleural mesothelioma.
     Eur J Cardiothorac Surg. 2016;49:1642-7.
     PubMed     Abstract available
     
     
     
112. WATANABE K, Tsuboi M, Sakamaki K, Nishii T, et al
     Postoperative follow-up strategy based on recurrence dynamics for non-small-cell lung cancer.
     Eur J Cardiothorac Surg. 2016;49:1624-31.
     PubMed     Abstract available
     
     
     
113. WALLER DA
     The staging of malignant pleural mesothelioma: are we any nearer to squaring the circle?
     Eur J Cardiothorac Surg. 2016;49:1648-9.
     PubMed    
     
     
     May 2016
114. SWANSON SJ
     The value of video-assisted thoracoscopic surgery: follow the money!
     Eur J Cardiothorac Surg. 2016;49:1496.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: